Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer

被引：0
|
作者：
Wendy Y Chen
Graham A Colditz
机构：
[1] Dana Farber Cancer Institute,WY Chen is an Attending Physician at the Department of Medical Oncology, and Associate Physician at the Department of Medicine
[2] Channing Laboratory,undefined
[3] Brigham and Women's Hospital,undefined
[4] and Instructor of Medicine at Harvard Medical School,undefined
[5] Boston,undefined
[6] MA.,undefined
[7] GA Colditz is the Neiss–Gain Professor in Medicine and Associate Director of Prevention and Control at the Alvin J Siteman Cancer Center,undefined
[8] Washington University School of Medicine,undefined
[9] St Louis,undefined
[10] WA,undefined
[11] USA.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Breast cancer is a heterogeneous group of diseases and hormone receptor status defines important clinical and etiologic differences between breast cancer subtypes. This article reviews the epidemiologic data on differences in risk factor associations by hormone receptor status, and highlights the limitations of commonly used prediction models. The authors describe how receptor status information can be applied to risk analysis for screening and preventive therapies.
引用
收藏
页码：415 / 423
页数：8
相关论文
共 50 条
  • [1] Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer
    Chen, Wendy Y.
    Colditz, Graham A.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 415 - 423
  • [2] Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status
    Huesing, Anika
    Canzian, Federico
    Beckmann, Lars
    Garcia-Closas, Montserrat
    Diver, W. Ryan
    Thun, Michael J.
    Berg, Christine D.
    Hoover, Robert N.
    Ziegler, Regina G.
    Figueroa, Jonine D.
    Isaacs, Claudine
    Olsen, Anja
    Viallon, Vivian
    Boeing, Heiner
    Masala, Giovanna
    Trichopoulos, Dimitrios
    Peeters, Petra H. M.
    Lund, Eiliv
    Ardanaz, Eva
    Khaw, Kay-Tee
    Lenner, Per
    Kolonel, Laurence N.
    Stram, Daniel O.
    Le Marchand, Loic
    McCarty, Catherine A.
    Buring, Julie E.
    Lee, I-Min
    Zhang, Shumin
    Lindstroem, Sara
    Hankinson, Susan E.
    Riboli, Elio
    Hunter, David J.
    Henderson, Brian E.
    Chanock, Stephen J.
    Haiman, Christopher A.
    Kraft, Peter
    Kaaks, Rudolf
    [J]. JOURNAL OF MEDICAL GENETICS, 2012, 49 (09) : 601 - 608
  • [3] DIETARY-FAT AND RISK OF BREAST-CANCER ACCORDING TO HORMONE-RECEPTOR STATUS
    KUSHI, LH
    POTTER, JD
    BOSTICK, RM
    DRINKARD, CR
    SELLERS, TA
    GAPSTUR, SM
    CERHAN, JR
    FOLSOM, AR
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1995, 4 (01) : 11 - 19
  • [4] Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women
    Schairer, Catherine
    Pfeiffer, Ruth M.
    Gadalla, Shahinaz M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (06) : 1202 - 1208
  • [5] Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer
    Bessonova, Leona
    Taylor, Thomas H.
    Mehta, Rita S.
    Zell, Jason A.
    Anton-Culver, Hoda
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) : 389 - 396
  • [6] Hormone-receptor status of breast cancer in Papua New Guinea
    Pip, A
    Watters, D
    Murthy, D
    Wood, N
    Donnelly, P
    [J]. LANCET, 1998, 351 (9112): : 1328 - 1329
  • [7] Risk of Breast Cancer in Relation to Combined Effects of Hormone Therapy, Body Mass Index, and Alcohol Use, by Hormone-receptor Status
    Hvidtfeldt, Ulla Arthur
    Tjonneland, Anne
    Keiding, Niels
    Lange, Theis
    Andersen, Ingelise
    Sorensen, Thorkild I. A.
    Prescott, Eva
    Hansen, Ase Marie
    Gronbaek, Morten
    Bojesen, Stig Egil
    Diderichsen, Finn
    Rod, Naja Hulvej
    [J]. EPIDEMIOLOGY, 2015, 26 (03) : 353 - 361
  • [8] SSRI use and breast cancer risk by hormone receptor status
    Coogan, Patricia F.
    Strom, Brian L.
    Rosenberg, Lynn
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 527 - 531
  • [9] SSRI use and breast cancer risk by hormone receptor status
    Patricia F. Coogan
    Brian L. Strom
    Lynn Rosenberg
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 527 - 531
  • [10] Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status
    Huang, WY
    Newman, B
    Millikan, RC
    Schell, MJ
    Hulka, BS
    Moorman, PG
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (07) : 703 - 714
12345